Immunotherapy-Related Endocrinopathy Management

Immunotherapy has become an important treatment for many cancers, using medications such as pembrolizumab, nivolumab and ipilimumab to activate the immune system and help it recognise and attack cancer cells. These therapies work by lifting the “brakes” on immune responses, but this increased activity can sometimes affect healthy tissues, including hormone-producing glands such as the thyroid, pituitary, adrenal glands and pancreas.

When the immune system mistakenly targets these glands, it can lead to changes in hormone levels that affect energy, metabolism, mood, blood pressure and overall well-being. Early detection and proper management of these endocrine side effects are essential to keep cancer treatment safe and effective. With timely monitoring and supportive care, most hormonal issues can be controlled while allowing patients to continue their immunotherapy whenever possible.

What are immunotherapy-related endocrinopathies? 

Immunotherapy-related endocrinopathies occur when checkpoint inhibitor medicines overstimulate the immune system and cause inflammation in hormone-producing glands. This immune-driven response can disrupt normal hormone production and lead to symptoms that affect energy, metabolism, blood pressure and glucose control.

Autoimmune inflammation may involve several glands, most commonly the thyroid, pituitary, adrenal glands and pancreas. In some cases the inflammation is temporary and hormone levels recover once the gland settles; in others, the damage leads to permanent hormone deficiency that requires long-term replacement therapy. Early recognition helps distinguish between short-term changes and lifelong hormone needs, ensuring that cancer treatment can continue safely.

Types of endocrine conditions caused by immunotherapy

Immunotherapy can affect different hormone glands, and recognising these patterns helps guide early diagnosis and management. The most frequent endocrine conditions include the following:

• Thyroid dysfunction — hyperthyroidism, hypothyroidism or thyroiditis that may progress from overactive to underactive function.

• Hypophysitis (pituitary inflammation) — reduced pituitary signals leading to low cortisol, low thyroid hormones and low sex hormones. 

• Adrenal insufficiency — primary or secondary adrenal failure caused by impaired cortisol production. 

• Diabetes mellitus — sudden-onset, immunotherapy-induced Type-1–like diabetes or severe hyperglycaemia requiring urgent treatment.

Early warning signs during immunotherapy treatment

Endocrine side effects from immunotherapy can appear gradually and may resemble everyday symptoms, which is why close attention is important. Recognising these early signs allows timely testing and management before more serious hormone imbalance develops.

• Fatigue or weakness — a persistent lack of energy that does not improve with rest.

• Weight changes — unexplained weight gain or loss linked to thyroid or cortisol changes. 

• Heat or cold intolerance — feeling unusually hot or cold due to altered thyroid function. 

• Headache or visual changes — symptoms that may indicate pituitary inflammation.

• Excessive thirst or frequent urination — early signs of immunotherapy-induced diabetes.

• Mood changes — irritability, anxiety or low mood related to hormone disruption.

• Nausea or dizziness — possible indicators of adrenal or pituitary hormone deficiency.

• Irregular periods or low libido — changes in reproductive hormones caused by gland inflammation.

Hormone testing and imaging during immunotherapy

Accurate diagnosis is essential because endocrine side effects can mimic cancer-related symptoms or general fatigue. Regular testing allows clinicians to distinguish temporary inflammation from lasting hormone deficiency and to decide when treatment adjustments are needed.

• Baseline and periodic thyroid function tests — monitoring TSH and thyroid hormones to detect early dysfunction.

• Cortisol, ACTH and pituitary hormone panels — assessing adrenal and pituitary function for signs of hypophysitis or adrenal insufficiency.

• Blood glucose and HbA1c — identifying immunotherapy-induced diabetes or early hyperglycaemia. 

• Electrolyte monitoring — checking sodium and potassium levels affected by adrenal or pituitary disorders.

• MRI of the pituitary — imaging used when symptoms suggest hypophysitis or other structural changes.

• Identifying long-term vs. transient dysfunction — determining whether inflammation will resolve or require lifelong hormone replacement.

Treatment strategies for immunotherapy-related endocrinopathy 

Endocrine side effects caused by immunotherapy can usually be managed without stopping cancer treatment as the priority is cancer remission and often stopping treatment does not stop the endocrine disruption. Management focuses on stabilising hormone levels, treating acute inflammation and ensuring long-term hormonal balance.

Hormone replacement therapies 

• Thyroxine for hypothyroidism — replaces low thyroid hormone to improve energy, mood and metabolism.

• Hydrocortisone for adrenal insufficiency — provides the cortisol needed for stress response, blood pressure and daily function.

• Sex hormone replacement when required — supports well-being when pituitary inflammation disrupts reproductive hormones.

• Insulin for immunotherapy-induced diabetes — controls high glucose levels and prevents serious complications.

Treating severe inflammation and urgent hormone imbalance

• Management of adrenal crisis — emergency stabilisation with IV hydrocortisone and fluids when cortisol levels drop dangerously low.

• Rapid glucose control — immediate treatment for severe hyperglycaemia or diabetic ketoacidosis linked to immunotherapy.

Monitoring and adjusting hormones for long-term care

• Regular hormone level checks — ensuring replacement doses remain safe and effective.

• Dose adjustments during illness or surgery — increasing hydrocortisone temporarily during stress or infection.

• Coordinated oncology–endocrinology care — ensuring cancer treatment continues safely while managing endocrine health.

Managing endocrine health during ongoing immunotherapy 

Most endocrine conditions caused by immunotherapy can be managed without stopping cancer treatment. Ongoing monitoring and coordinated care ensure that hormone levels remain stable while allowing immunotherapy to continue whenever possible.

• When immunotherapy can continue safely — stable hormone levels and effective symptom control allow treatment to proceed as planned.

• When temporary interruption is needed — severe inflammation, adrenal crisis or uncontrolled diabetes may require short pauses.

• Coordinated care between oncologists and endocrinologists — joint decision-making helps balance cancer control with endocrine safety.

• Monitoring schedules based on treatment type — regular blood tests and symptom reviews tailored to the specific immunotherapy regimen.

Lifestyle and supportive measures for immunotherapy-related endocrinopathy 

Lifestyle changes play an important role in managing fatigue, metabolic changes and hormonal instability caused by immunotherapy. These measures support energy levels, mood, glucose control and general resilience throughout treatment.

• Balanced nutrition — eating regular, nutrient-rich meals to support glucose stability, weight control and overall metabolic health.

• Regular physical activity — aerobic exercise and strength-based exercises that improve stamina, reduces fatigue and supports mood. 

• Stress management and sleep hygiene — techniques that stabilise emotional well-being and improve sleep quality. 

• Education on sick-day rules for adrenal insufficiency — guidance on adjusting hydrocortisone during illness or stress.

• Recognising signs of glucose changes — understanding symptoms of high or low blood sugar for early, safe correction. 

When to seek urgent care for immunotherapy-related endocrinopathy 

Some endocrine complications can become serious if not recognised early. Knowing the warning signs helps ensure timely medical attention and prevents life-threatening hormone deficiencies or metabolic crises.

• Severe headache with vomiting or vision changes — possible signs of pituitary inflammation (hypophysitis) requiring urgent assessment. 

• Extreme fatigue, low blood pressure or fainting — indicators of adrenal insufficiency or adrenal crisis that need emergency treatment. 

• Excessive thirst with frequent urination — early symptoms of immunotherapy-induced diabetes or dangerously high glucose levels. 

• Fever with worsening weakness — a risk in adrenal insufficiency where cortisol levels are too low to cope with physical stress/ illness. 

• Rapid heart rate or shortness of breath — potential metabolic or thyroid-related complications that require prompt evaluation. 

Potential benefits of early management for immunotherapy-related endocrinopathy 

Recognising endocrine changes early allows timely treatment, reduces complications and helps patients tolerate immunotherapy more effectively. Early intervention also supports better long-term hormonal stability and overall well-being during cancer care.

• Improved tolerance of immunotherapy — managing hormone issues helps patients stay on treatment safely.

• Reduced risk of hospitalisation — early correction of thyroid, adrenal or glucose abnormalities prevents severe complications.

• Lower likelihood of adrenal crisis — prompt treatment of adrenal insufficiency protects against life-threatening events.

• Better quality of life — treatment of fatigue, mood changes and metabolic shifts improves daily functioning.

• Stable long-term hormonal health — early management supports gland recovery when possible and guides lifelong replacement when needed.

Summary

Immunotherapy has improvised cancer care, but its benefits can come with unintended effects on hormone-producing glands. These endocrine changes may cause symptoms affecting energy, metabolism, mood, blood pressure and glucose control, and in some cases can lead to long-term hormone deficiency. With early recognition, regular monitoring and timely hormone replacement, most endocrine complications can be managed safely without interrupting life-saving cancer treatment. 

A structured approach that combines medical management, lifestyle support and coordinated care between oncology and endocrinology helps protect overall health and ensures patients continue treatment with greater comfort and confidence.

If you are experiencing symptoms during immunotherapy or are concerned about possible hormone-related side effects, schedule a consultation with The Metabolic Clinic for comprehensive assessment and personalised endocrine management throughout your cancer treatment.

Frequently Asked Questions (FAQs)